BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price reached a new 52-week high on Monday . The stock traded as high as $1.64 and last traded at $1.60, with a volume of 6347 shares changing hands. The stock had previously closed at $1.62.
BioRestorative Therapies Trading Down 1.2 %
The business has a fifty day moving average price of $1.65 and a two-hundred day moving average price of $1.52. The company has a market cap of $2.62 billion, a price-to-earnings ratio of -1.51 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Read More
- Five stocks we like better than BioRestorative Therapies
- 3 Best Fintech Stocks for a Portfolio Boost
- Survey: Top 175 Fittest Retirement Locations in America
- What Are Dividends? Buy the Best Dividend Stocks
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.